Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Lymphoid 1CNS 1

Conditions

Glioma 3Central Nervous System Neoplasms 3Astrocytoma 3Oligodendroglioma 2Neurofibromatosis 1 2Brain Neoplasms 2Rhabdoid Tumor 1Recurrence 1Precancerous Conditions 1Optic Nerve Glioma 1Neurofibroma, Plexiform 1Neoplasms 1Melanoma 1Gliosarcoma 1Glioma, Subependymal 1Glioblastoma 1Ependymoma 1Choroid Plexus Neoplasms 1

Interventions

Temozolomide 19Bevacizumab 14Irinotecan 12Carboplatin 10Cyclophosphamide 9Radiosurgery 8Lomustine 8Radiotherapy 7pembrolizumab 6Vincristine 6Topotecan 6Drug Therapy 6Surgical Procedures, Operative 5Etoposide 5Doxorubicin 5Cisplatin 53-Iodobenzylguanidine 5trametinib 4Metformin 4Gemcitabine 4Dexamethasone 4Blood Specimen Collection 4poly ICLC 3dabrafenib 3Vorinostat 3Trastuzumab 3Therapeutics 3Radiation 3Paclitaxel 3Observation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Vinblastine × CNS × Clear all
NCT00213278 2014-11-20

Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma

The Hospital for Sick Children

Phase 2 Completed
50 enrolled
CNS

Brain Neoplasms, Glioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡